SCHEMBL25681519

SCHEMBL25681519

Cn1c(N)nc2cc(-c3ccncc3)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 1/20 0.47
▸ PIK3CD O00329 2/20 0.46
▸ PIK3CA P42336 2/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ PIP5K1C O60331 1/20 0.46
▸ PI4KA P42356 1/20 0.46
▸ PI4KB Q9UBF8 1/20 0.46
▸ AAK1 Q2M2I8 5/20 0.46
▸ NTRK1 P04629 1/20 0.44
▸ CSF1R P07333 1/20 0.44
▸ NTRK2 Q16620 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PDPK1 O15530 2/20 0.41
▸ QDPR P09417 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682150 0.83 ALOX5AP (0.39) ALOX5APAAK1NTRK1CSF1RNTRK2
SCHEMBL25681516 0.83 NTRK1 (0.45) ALOX5APPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL34467103 0.82 ALOX5AP (0.52) ALOX5APPIK3CDPIK3CAPIP5K1CPI4KA
SCHEMBL25681517 0.82 ALOX5AP (0.52) ALOX5APPIK3CDPIK3CAPIP5K1CPI4KA
SCHEMBL25168404 0.80 ABL1 (0.51) ALOX5APKDM4ENPC1ALDH1A1POLB
SCHEMBL31258632 0.80 ABL1 (0.51) ALOX5APKDM4ENPC1ALDH1A1POLB
SCHEMBL31258639 0.77 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPI4KA
SCHEMBL25168401 0.77 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPI4KA
SCHEMBL25167938 0.77 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPI4KA
SCHEMBL31258618 0.77 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-23 — — US disclosed
WO-2023081367-A2 2-AMINO IMIDAZOLE DERIVATIVES Mirati Therapeutics, Inc. (US) 2023-05-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 ALOX5AP 4763/4885PIK3CD 2161/4885PIK3CA 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback